J
Jan C. Grutters
Researcher at Utrecht University
Publications - 311
Citations - 9976
Jan C. Grutters is an academic researcher from Utrecht University. The author has contributed to research in topics: Idiopathic pulmonary fibrosis & Medicine. The author has an hindex of 49, co-authored 269 publications receiving 7794 citations. Previous affiliations of Jan C. Grutters include University Medical Center Utrecht & Paris Diderot University.
Papers
More filters
Journal Article
The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool
Marc A. Judson,Ulrich Costabel,Marjolein Drent,Athol U. Wells,Lisa A. Maier,Laura L. Koth,Hidenobu Shigemitsu,Dan A. Culver,Jeffrey M. Gelfand,Dominique Valeyre,Nadera J. Sweiss,Elliott D. Crouser,Adam S. Morgenthau,Elyse E. Lower,Arata Azuma,Mami Ishihara,Shin-ichiro Morimoto,Tetsuo Tetsuo Yamaguchi,Noriharu Shijubo,Jan C. Grutters,Misha Rosenbach,Huiping Li,Paola Rottoli,Yoshikazu Inoue,Antje Prasse,Robert P. Baughman +25 more
TL;DR: An instrument was developed by expert opinion that may be useful for the clinician and researcher in establishing criteria for sarcoidosis organ involvement.
Journal ArticleDOI
Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort study.
Simon L.F. Walsh,Athol U. Wells,Sujal R. Desai,Venerino Poletti,Sara Piciucchi,Alessandra Dubini,Hilario Nunes,Dominique Valeyre,Pierre Yves Brillet,Marianne Kambouchner,António Morais,José Manuel Pereira,Conceição Souto Moura,Jan C. Grutters,Daniel A F van den Heuvel,Hendrik W. van Es,Matthijs F.M. van Oosterhout,Cornelis A Seldenrijk,Elisabeth Bendstrup,Finn Rasmussen,Line Bille Madsen,Bibek Gooptu,Sabine Pomplun,Hiroyuki Taniguchi,Junya Fukuoka,Takeshi Johkoh,Andrew G. Nicholson,Charlie Sayer,Lilian Edmunds,Joseph Jacob,Maria Kokosi,Jeffrey L. Myers,Kevin R. Flaherty,David M. Hansell +33 more
TL;DR: Inter-multidisciplinary team agreement for diagnosis in diffuse lung disease is acceptable and good for a diagnosis of IPF, as validated by the non-significant greater prognostic separation of an IPF diagnosis made by MDTMs than the separation of a diagnoses made by individual clinicians or radiologists.
Journal ArticleDOI
Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial
Sabine C. A. Meijvis,Hans Hardeman,Hilde H F Remmelts,Hilde H F Remmelts,Rik Heijligenberg,Ger T. Rijkers,Heleen van Velzen-Blad,G Paul Voorn,Ewoudt M W van de Garde,Henrik Endeman,Jan C. Grutters,Willem Jan W. Bos,Douwe H. Biesma +12 more
TL;DR: In this paper, a double-blind, placebo-controlled trial was conducted to assess the effect of addition of dexamethasone on length of stay in patients with community-acquired pneumonia.
Journal ArticleDOI
MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease.
Pierre-Antoine Juge,Joyce S. Lee,Esther Ebstein,Hiroshi Furukawa,Evgenia Dobrinskikh,Steven Gazal,Caroline Kannengiesser,Sébastien Ottaviani,Shomi Oka,Shigeto Tohma,Naoyuki Tsuchiya,Jorge Rojas-Serrano,Montserrat I González-Pérez,Mayra Mejía,Ivette Buendía-Roldán,Ramcés Falfán-Valencia,Enrique Ambrocio-Ortiz,Effrosyni D. Manali,Spyros Papiris,Theofanis Karageorgas,Dimitrios Boumpas,Katarina M. Antoniou,Coline H.M. van Moorsel,Joanne J. van der Vis,Yaël A de Man,Jan C. Grutters,Yaping Wang,Raphael Borie,Lidwine Wemeau-Stervinou,Benoit Wallaert,René-Marc Flipo,Hilario Nunes,Dominique Valeyre,Nathalie Saidenberg-Kermanac’h,Marie-Christophe Boissier,Sylvain Marchand-Adam,Aline Frazier,Pascal Richette,Yannick Allanore,Jean Sibilia,Claire Dromer,Christophe Richez,Thierry Schaeverbeke,Huguette Lioté,Gabriel Thabut,Nadia Nathan,S. Amselem,Martin Soubrier,Vincent Cottin,Annick Clement,Kevin D. Deane,Avram D Walts,Tasha E. Fingerlin,Aryeh Fischer,Jay H. Ryu,Eric L. Matteson,Timothy B Niewold,Deborah Assayag,Andrew J. Gross,Paul J. Wolters,Marvin I. Schwarz,Michael Holers,Joshua J. Solomon,Tracy J. Doyle,Ivan O. Rosas,Cornelis Blauwendraat,Michael A. Nalls,Marie-Pierre Debray,Catherine Boileau,Bruno Crestani,David A. Schwartz,Philippe Dieudé +71 more
TL;DR: It is found that the MUC5B promoter variant was associated with rheumatoid arthritis and more specifically associated with evidence of usual interstitial pneumonia on imaging and associated with an increased risk of ILD among patients with RA.
Journal ArticleDOI
Efficacy of infliximab in extrapulmonary sarcoidosis: Results from a randomised trial
Marc A. Judson,Robert P. Baughman,U Costabel,Susan Flavin,Kim Hung Lo,Mani S. Kavuru,Marjolein Drent,Daniel A. Culver,Gerald S. Davis,C.M. Fogarty,Gary W. Hunninghake,Alvin S. Teirstein,M. Mandel,Daniel McNally,L. Tanoue,Lee S. Newman,Y. Wasfi,Herbert Patrick,Milton D. Rossman,Ganesh Raghu,Om P. Sharma,David S. Wilkes,Henry Yeager,J.F. Donahue,M. Kaye,Nadera J. Sweiss,N. Vetter,Michiel Thomeer,Martin Brutsche,Laurent P. Nicod,Dominique Valeyre,P. Chanez,C Albera,Jan C. Grutters,Henk C. Hoogsteden,Joachim Müller-Quernheim,R. Bonnet,F. Kanniess +37 more
TL;DR: Infliximab may be beneficial compared with placebo in the treatment of extrapulmonary sarcoidosis in patients already receiving corticosteroids, as assessed by the severity tool described in the present study.